Indication
LOTEMAX
®
GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of
post-operative infl ammation and pain following ocular surgery.
Important Safety Information about LOTEMAX
®
GEL
• LOTEMAX
®
GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes
simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the
eye and fungal diseases of ocular structures.
• Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual
acuity and fields of vision. If this product is used for 10 days or longer, IOP should be monitored.
• Use of corticosteroids may result in posterior subcapsular cataract formation.
• Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation and
occurrence of perforations in those with diseases causing corneal and scleral thinning. The initial prescription
and renewal of the medication order should be made by a physician only after examination of the patient with
the aid of magnification, and where appropriate, fluorescein staining.
• Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular
infection. In acute purulent conditions, steroids may mask infection or enhance existing infection.
• Use of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great
caution. Use of ocular steroids may prolong the course and exacerbate the severity of many viral infections of
the eye (including herpes simplex).
• Fungal infections of the cornea are particularly prone to develop coincidentally
with long-term local steroid application. Fungus invasion must be considered
in any persistent corneal ulceration where a steroid has been used or is in use.
• Patients should not wear contact lenses when using LOTEMAX
®
GEL.
• The most common ocular adverse drug reactions reported were anterior
chamber inflammation (5%), eye pain (2%) and foreign body sensation (2%).
Please see brief summary of Prescribing Information on adjacent page.
®/™ are trademarks of Bausch & Lomb Incorporated or its a liates. © 2015 Bausch & Lomb Incorporated. All rights reserved. Printed in USA. US/LGX/15/0041
Down, Boy.
Help Tame Postoperative Ocular Inflammation
and Pain With LOTEMAX
®
GEL
